Literature DB >> 12169999

The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer.

Eric M Rohren1, Erik K Paulson, Rosalie Hagge, Terrence Z Wong, James Killius, Pierre-Alain Clavien, Rendon C Nelson.   

Abstract

PURPOSE: The authors' goal was to determine the sensitivity and specificity of F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) for identifying patients with hepatic metastases from colorectal cancer and the accuracy of PET for determining the number and distribution of lesions within the liver. Intraoperative sonography and surgical inspection and palpation were used as the reference standard.
METHODS: Twenty-three patients being evaluated for surgical resection of hepatic metastases from colorectal carcinoma underwent FDG PET before operation. Findings of the PET studies were reviewed in a blinded, retrospective manner, with the results compared with the findings of intraoperative sonography and surgical exploration. Lesions of all sizes were considered in the analysis.
RESULTS: The FDG-PET results were positive in 21 of the 22 patients ultimately found to have metastatic disease to the liver, and they were negative in the single patient without metastases. Therefore, for identification of patients with hepatic metastatic disease, PET has a sensitivity of 95% and a specificity of 100%. In all, 48 metastatic lesions were identified in these patients, of which 38 (79%) were identified on PET images. The probability of lesion detection by PET was directly correlated with lesion size (P < 0.01). The assessment of lobar disease distribution in the liver was discordant between PET and surgery in 3 of 23 (13%) patients.
CONCLUSIONS: In patients being evaluated for potential curative resection of hepatic metastases from colorectal cancer, FDG PET is accurate for the identification of the presence or absence of metastatic disease to the liver. However, detection of individual lesions depends on their size, and determination of lesion number and distribution within the liver is more accurately accomplished with intraoperative sonography.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169999     DOI: 10.1097/00003072-200208000-00002

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  17 in total

1.  Guidelines for resection of colorectal cancer liver metastases.

Authors:  O J Garden; M Rees; G J Poston; D Mirza; M Saunders; J Ledermann; J N Primrose; R W Parks
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

Review 2.  Restaging of colorectal cancer and PET/CT.

Authors:  Alev Çınar; Esra Arzu Gençoğlu; Meliha Korkmaz
Journal:  Ulus Cerrahi Derg       Date:  2013-06-01

3.  Positron emission tomography/computed tomography in the staging of colon cancer.

Authors:  Jae Hyung Lee; Min Ro Lee
Journal:  Ann Coloproctol       Date:  2014-02-28

4.  Positron emission tomography for staging and assessment of tumor response of hepatic malignancies.

Authors:  Robert S Hellman; Arthur Z Krasnow; Gary S Sudakoff
Journal:  Semin Intervent Radiol       Date:  2006-03       Impact factor: 1.513

5.  Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer.

Authors:  Jinyu Gu; Hirofumi Yamamoto; Hiroki Fukunaga; Katsuki Danno; Ichiro Takemasa; Masataka Ikeda; Mitsuaki Tatsumi; Mitsugu Sekimoto; Jun Hatazawa; Tsunehiko Nishimura; Morito Monden
Journal:  Dig Dis Sci       Date:  2006-11-02       Impact factor: 3.199

6.  Role of PET/CT in the detection of liver metastases from colorectal cancer.

Authors:  A Orlacchio; O Schillaci; N Fusco; P Broccoli; M Maurici; M Yamgoue; R Danieli; S D'Urso; G Simonetti
Journal:  Radiol Med       Date:  2009-05-14       Impact factor: 3.469

7.  The impact of intraoperative ultrasonography on the surgical treatment of patients with colorectal liver metastases.

Authors:  C Sietses; M R Meijerink; S Meijer; M P van den Tol
Journal:  Surg Endosc       Date:  2010-01-29       Impact factor: 4.584

8.  Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases.

Authors:  Kenneth Coenegrachts; Frank De Geeter; Leon ter Beek; Natascha Walgraeve; Shandra Bipat; Jaap Stoker; Hans Rigauts
Journal:  Eur Radiol       Date:  2008-09-16       Impact factor: 5.315

Review 9.  Positron emission tomography/computer tomography: challenge to conventional imaging modalities in evaluating primary and metastatic liver malignancies.

Authors:  Long Sun; Hua Wu; Yong-Song Guan
Journal:  World J Gastroenterol       Date:  2007-05-28       Impact factor: 5.742

10.  Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer.

Authors:  Jose Manuel Llamas-Elvira; Antonio Rodríguez-Fernández; Javier Gutiérrez-Sáinz; Manuel Gomez-Rio; María Bellon-Guardia; Carlos Ramos-Font; Angel Custodio Rebollo-Aguirre; Dolores Cabello-García; Antonio Ferrón-Orihuela
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-29       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.